Summary

Thermoformed Medical Packaging Market Research Report by Material (PETG, APET, PP, PS, PVC, Others), by Packaging Type (Primary Packaging, Secondary Packaging), by Application (Medical Devices & Instruments, Pharmaceuticals & Drug Delivery, Implants & Prosthetics, Surgical & Wound Care Products, Others), by End User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers), by Region (North America, Europe, Asia-Pacific, Middle East & Africa, South America) Forecast till 2035

Market Overview
The global thermoformed medical packaging market is anticipated to reach a significant market expansion at a CAGR of 4.8% during the forecast period to surpass a market value of USD 14.1 billion by the end of 2035. A common industrial technique for producing high-tolerance plastic packaging in large quantities is thermoforming. To generate a certain shape, a plastic sheet is heated until it becomes malleable and then shaped over a mold. The plastic keeps the mold's shape after cooling and solidifying.
The Global Thermoformed Medical Packaging Market has two main drivers: firstly, a surging demand for sterile and safe packaging. This is fueled by increased awareness of patient safety, the rise in hospital-acquired infections (HAIs), and stringent regulations from bodies like the U.S. FDA and ISO.
Secondly, advancements in material technology and sustainability trends are significantly impacting the market. While traditional materials like PVC and PETG are still used, there's a strong shift towards bio-based, compostable, and recycled materials such as PLA and rPET, driven by environmental concerns and regulatory pressures for a more circular economy in healthcare packaging.
The high cost of raw materials and manufacturing is one of the significant barriers of the thermoformed medical packaging market. The thermoforming process has numerous expenditures in addition to material costs. It requires precise molds, cleanroom spaces, and specialized equipment, all of which come with a high cost. Increasing demand for eco-friendly and sustainable packaging solutions are now reshaping the thermoformed medical packaging industry.

Market Segmentations
The global thermoformed medical packaging market is segmented based on the material, which includes PETG, APET, PP, PS, and PVC.
Primary packaging and secondary packaging are the two types of packaging type of the global thermoformed medical packaging market.
Depending on the application, the global market is divided into medical devices & instruments, pharmaceuticals & drug delivery, implants & prosthetics, and surgical & wound care products.
In terms of the end user, the global thermoformed medical packaging market is classified into pharmaceutical & biotechnology companies and medical device manufacturers.

Regional Insights
North America presents a strong growth opportunity for the global thermoformed medical packaging market, driven by advanced healthcare infrastructure, stringent regulatory standards, and increasing demand for sterile, high-performance packaging. The regional market focuses on reshoring manufacturing, and clean energy sectors further boost demand for innovative, sustainable medical packaging solutions.
Europe offers promising growth for the global Thermoformed Medical Packaging market, fueled by increasing sustainability initiatives, smart manufacturing, and stringent environmental regulations under the EU Green Deal. With rising demand for eco-friendly, high-performance medical packaging across key markets like Germany, France, and Eastern Europe, the region is advancing toward innovative and compliant packaging solutions.
In 2024, the Asia-Pacific region dominated the global Thermoformed Medical Packaging market, and it is anticipated to develop at the fastest rate throughout the forecast period. Rapid urbanization, rising middle-class populations, and robust government initiatives are the main demand factors propelling the Asia-Pacific market, which is the largest and fastest-growing area for industrial building.
Industrial diversification and strategic investments across the Middle East and Africa region, led by initiatives like Saudi Arabia’s Vision 2030 and the UAE’s non-oil sector expansion, are unlocking new opportunities for the global thermoformed medical packaging market.
The South America region presents emerging opportunities for the Global Thermoformed Medical Packaging Market, supported by growth in sectors like agribusiness, food processing, and energy, particularly in Brazil, Argentina, Chile, and Peru. Despite economic uncertainties, ongoing industrial development and investments in logistics and infrastructure create a promising landscape for medical packaging expansion in the region.

Major Players
Major rivals of the global thermoformed medical packaging market are Prent Corporation, Dordan Manufacturing Company, Incorporated, Amcor Plc, Toppan Holdings Inc., Winpak Ltd., Placon Corporation, T.O. Plastics, Inc., Brentwood Industries, Inc., TekniPlex, Inc., and Nelipak.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ............................................... 25
2 MARKET INTRODUCTION ............................................ 27
2.1 DEFINITION .................................. 27
2.2 SCOPE OF THE STUDY .............. 27
2.3 RESEARCH OBJECTIVE ............ 27
2.4 MARKET STRUCTURE .............. 28
3 RESEARCH METHODOLOGY ...................................... 29
3.1 OVERVIEW .................................... 29
3.2 DATA FLOW .................................. 31
3.2.1 Data Mining Process ....... 31
3.3 PURCHASED DATABASE: ......... 32
3.4 SECONDARY SOURCES: ............ 33
3.4.1 Secondary Research data flow: ........................................................ 34
3.5 PRIMARY RESEARCH: ............... 35
3.5.1 Primary Research DATA FLOW: ....................................................... 36
3.5.2 Primary Research: Number of Interviews conducted ........................ 37
3.5.3 Primary Research: Regional Coverage ............................................. 37
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........................... 38
3.6.1 Revenue Analysis Approach ............................................................ 38
3.7 DATA FORECASTING................. 39
3.7.1 Data forecasting Technique ............................................................ 39
3.8 DATA MODELING ........................ 40
3.8.1 microeconomic factor analysis: ....................................................... 40
3.8.2 Data modeling: ............... 41
3.9 TEAMS AND ANALYST CONTRIBUTION ........................................... 42
4 MARKET DYNAMICS .................................................... 43
4.1 INTRODUCTION ........................... 43
4.2 DRIVERS ......................................... 44
4.2.1 Increasing Demand for Sterile and Safe Packaging ........................... 44
4.2.2 Advancements in Material Technology and Sustainability Trends ...... 44
4.2.3 DRIVERS IMPACT ANALYSIS ........................................................... 45
4.3 RESTRAINT .................................. 45
4 .3.1 High Cost of Raw Materials and Manufacturing ................................ 45
4.4 OPPORTUNITIES ......................... 46
4.4.1 Growing Demand for Sustainable and Eco-Friendly Packaging Solutions ............................................................ 46
4.5 COVID 19 IMPACT ANALYSIS ................................................................. 47
4.5.1 covid 19 impact on the GLOBAL THERMOFORMED MEDICAL PACKAGING MARKET ........................................... 47
4.5.1.1 ECONOMIC IMPACT ............................................................... 47
4.5.2 Impact on Supply Chain on GLOBAL THERMOFORMED MEDICAL PACKAGING MARKET ..................................... 47
4.5.2.1 Impact on Price Variation of Key Raw Materials ....................... 47
4.5.2.2 Cash Flow Constraints ............................................................ 47
4.5.2.3 Impact on Import/Export ......................................................... 48
4.5.3 Impact on Market Demand .............................................................. 48
4.5.3.1 Impact due to restrictions/lockdown ....................................... 48
4.5.3.2 Consumer Sentiments ............................................................ 48
4.5.4 Impact on Pricing on GLOBAL THERMOFORMED MEDICAL PACKAGING MARKET .............................................. 49
5 MARKET FACTOR ANALYSIS ...................................... 50
5.1 SUPPLY/ VALUE CHAIN ANALYSIS .................................................... 50
5.1.1 raw material/Materials providers ..................................................... 51
5.1.2 MANUFACTURING .......... 51
5.1.3 distributors & retailers .................................................................... 51
5.1.4 end user ......................... 51
5.2 PORTER’S FIVE FORCES MODEL ........................................................... 52
5.2.1 THREAT OF NEW ENTRANTS ........................................................... 52
5.2.2 BARGAINING POWER OF SUPPLIERS ............................................... 53
5.2.3 THREAT OF SUBSTITUTES .............................................................. 53
5.2.4 BARGAINING POWER OF BUYERS .................................................... 53
5.2.5 INTENSITY OF RIVALRY .................................................................. 54
6 GLOBAL THERMOFORMED MEDICAL PACKAGING MARKET, BY MATERIAL ......................... 55
6.1 INTRODUCTION ........................... 55
6.2 PETG (POLYETHYLENE TEREPHTHALATE GLYCOL) ................... 56
6.3 APET (AMORPHOUS POLYETHYLENE TEREPHTHALATE) ........ 56
6.4 PP (POLYPROPYLENE) .............. 56
6.5 PS (POLYSTYRENE) ................... 57
6.6 PVC (POLYVINYL CHLORIDE) ................................................................. 57
6.7 OTHERS (PC, HDPE, ETC.) ......... 58
7 GLOBAL THERMOFORMED MEDICAL PACKAGING MARKET, BY PACKAGING TYPE ............ 59
7.1 INTRODUCTION ........................... 59
7.2 ARY PACKAGING ........................ 61
7.2.1 BLISTER PACKS .............. 61
7.2.2 CLAMSHELLS ................. 61
7.2.3 TRAYS ........................... 62
7.2.4 POUCHES LIDS ............... 62
7.2.5 VIALS AND BOTTLES ...... 62
7.2.6 OTHERS ......................... 63
7.3 SECONDARY PACKAGING........ 63
7.3.1 CARTONS ....................... 63
7.3.2 Boxes ............................ 63
7.3.3 WRAPS .......................... 64
7.3.4 OTHER ........................... 64
8 GLOBAL THERMOFORMED MEDICAL PACKAGING MARKET, BY APPLICATION ................... 65
8.1 INTRODUCTION ........................... 65
8.2 MEDICAL DEVICES & INSTRUMENTS ................................................. 68
8.2.1 Surgical Instruments ....... 68
8.2.2 CATHETERS ................... 68
8.2.3 DIAGNOSTIC EQUIPMENT ............................................................... 68
8.2.4 OTHERS ......................... 69
8.3 PHARMACEUTICALS & DRUG DELIVERY .......................................... 69
8.3.1 INJECTABLES ................. 69
8.3.2 TABLETS CAPSULES ....... 69
8.4 IMPLANTS & PROSTHETICS ................................................................... 70
8.4.1 ORTHOPEDIC IMPLANTS ................................................................ 70
8.4.2 CARDIOVASCULAR IMPLANTS ........................................................ 70
8.4.3 OTHERS ......................... 70
8.5 SURGICAL & WOUND CARE ..................................................................... 71
8.5.1 SUTURES DRESSINGS ..................................................................... 71
8.5.2 SURGICAL KITS .............. 71
8.5.3 OTHERS ......................... 71
8.6 OTHERS .......................................... 71
9 GLOBAL THERMOFORMED MEDICAL PACKAGING MARKET, BY END-USER ........................ 72
9.1 INTRODUCTION ........................... 72
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ................. 73
9.3 MEDICAL DEVICE MANUFACTURERS ................................................ 73
10 GLOBAL THERMOFORMED MEDICAL PACKAGING MARKET, BY REGION ............................. 74
10.1 OVERVIEW .................................... 74
10.2 NORTH AMERICA ....................... 75
10.2.1 US.................................. 79
10.2.2 canada ........................... 82
10.2.3 Mexico ........................... 86
10.3 EUROPE .......................................... 90
10.3.1 germany ......................... 94
10.3.2 UK ................................. 97
10.3.3 france ............................ 100
10.3.4 russia ............................ 104
10.3.5 italy ............................... 107
10.3.6 spain ............................. 110
10.3.7 rest of europe ................. 114
10.4 ASIA-PACIFIC ............................... 118
10.4.1 china.............................. 122
10.4.2 india .............................. 125
10.4.3 japan ............................. 128
10.4.4 south korea .................... 132
10.4.5 malaysia ........................ 135
10.4.6 thailand .......................... 139
10.4.7 rest of asia-pacific .......... 142
10.5 MIDDLE EAST & AFRICA .......... 146
10.5.1 gcc countries ................. 150
10.5.2 south africa .................... 153
10.5.3 rest of MEA .................... 157
10.6 SOUTH AMERICA ....................... 161
10.6.1 brazil ............................. 165
10.6.2 argentina........................ 168
10.6.3 rest of south america ...... 172
11 COMPETITIVE LANDSCAPE ........................................ 176
11.1 INTRODUCTION ........................... 176
11.2 MARKET SHARE ANALYSIS, 2024 ....................................................... 176
11.3 COMPETITOR DASHBOARD..................................................................... 177
11.4 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL .............. 178
1 1.5 THE LEADING PLAYER IN TERMS OF THE NUMBER OF RECENT DEVELOPMENTS IN THE MARKET
........................................................... 178
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ............................ 179
11.6.1 product launch ............... 179
11.6.2 Contracts, agreement, collaboration & parnership ............................ 180
11.6.3 expansion ...................... 180
11.6.4 Acquisition ..................... 181
12 COMPANY PROFILES .................................................. 182
12.1 AMCOR PLC................................... 182
12.1.1 COMPANY OVERVIEW ..................................................................... 182
12.1.2 FINANCIAL OVERVIEW .................................................................... 183
12.1.3 PRODUCTS OFFERED ...... 183
12.1.4 KEY DEVELOPMENTS ...... 184
12.1.5 SWOT ANALYSIS ............ 184
12.1.6 KEY STRATEGIES ............ 185
12.2 TOPPAN HOLDINGS INC. .......... 186
12.2.1 COMPANY OVERVIEW ..................................................................... 186
12.2.2 FINANCIAL OVERVIEW .................................................................... 187
12.2.3 PRODUCTS OFFERED ...... 187
12.2.4 KEY DEVELOPMENTS ...... 187
12.2.5 SWOT ANALYSIS ............ 188
12.2.6 KEY STRATEGIES ............ 188
12.3 WINPAK LTD. ............................... 190
12.3.1 COMPANY OVERVIEW ..................................................................... 190
12.3.2 FINANCIAL OVERVIEW .................................................................... 191
12.3.3 PRODUCTS OFFERED ...... 191
12.3.4 KEY DEVELOPMENTS ...... 192
12.3.5 SWOT ANALYSIS ............ 192
12.3.6 KEY STRATEGIES ............ 193
12.4 PLACON CORPORATION ........... 194
12.4.1 COMPANY OVERVIEW ..................................................................... 194
12.4.2 FINANCIAL OVERVIEW .................................................................... 194
12.4.3 PRODUCTS OFFERED ...... 194
12.4.4 KEY DEVELOPMENTS ...... 194
12.4.5 SWOT ANALYSIS ............ 195
12.4.6 KEY STRATEGIES ............ 195
12.5 DORDAN MANUFACTURING COMPANY, INCORPORATED.......... 196
12.5.1 COMPANY OVERVIEW ..................................................................... 196
12.5.2 FINANCIAL OVERVIEW .................................................................... 196
12.5.3 PRODUCTS OFFERED ...... 196
12.5.4 KEY DEVELOPMENTS ...... 196
12.5.5 SWOT ANALYSIS ............ 196
12.5.6 KEY STRATEGIES ............ 197
12.6 PRENT CORPORATION .............. 198
12.6.1 COMPANY OVERVIEW ..................................................................... 198
12.6.2 FINANCIAL OVERVIEW .................................................................... 198
12.6.3 PRODUCTS OFFERED ...... 198
12.6.4 KEY DEVELOPMENTS ...... 198
12.6.5 SWOT ANALYSIS ............ 199
12.6.6 KEY STRATEGIES ............ 199
12.7 T.O. PLASTICS, INC. .................... 201
12.7.1 COMPANY OVERVIEW ..................................................................... 201
12.7.2 FINANCIAL OVERVIEW .................................................................... 201
12.7.3 PRODUCTS OFFERED ...... 201
12.7.4 KEY DEVELOPMENTS ...... 201
12.7.5 SWOT ANALYSIS ............ 201
12.7.6 KEY STRATEGIES ............ 202
12.8 BRENTWOOD INDUSTRIES, INC............................................................. 203
12.8.1 COMPANY OVERVIEW ..................................................................... 203
12.8.2 FINANCIAL OVERVIEW .................................................................... 203
12.8.3 PRODUCTS OFFERED ...... 203
12.8.4 KEY DEVELOPMENTS ...... 203
12.8.5 SWOT ANALYSIS ............ 204
12.8.6 KEY STRATEGIES ............ 204
12.9 TEKNI-PLEX, INC. ....................... 206
12.9.1 COMPANY OVERVIEW ..................................................................... 206
12.9.2 FINANCIAL OVERVIEW .................................................................... 206
12.9.3 PRODUCTS OFFERED ...... 206
12.9.4 KEY DEVELOPMENTS ...... 206
12.9.5 SWOT ANALYSIS ............ 207
12.9.6 KEY STRATEGIES ............ 207
12.10 NELIPAK ........................................ 209
12.10.1 COMPANY OVERVIEW ..................................................................... 209
12.10.2 FINANCIAL OVERVIEW .................................................................... 209
12.10.3 PRODUCTS OFFERED ...................................................................... 209
12.10.4 KEY DEVELOPMENTS ...... 210
12.10.5 SWOT ANALYSIS ............ 210
12.10.6 KEY STRATEGIES ............ 211